Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications rac1b overexpression correlates poor prognosis krasbraf wt metastatic colorectal cancer
… Evidence of Effective Treatment in Non-Small-Cell Lung Cancer with Capmatinib Share on: February 27, 2023 Non-small … cell lung cancer (NSCLC) is an aggressive disease, with poor prognosis and a high likelihood of brain metastases. Overall …
… generally diagnosed at early stages of the disease when prognosis is favorable. Mutations in the RET gene are … the recommended genetic testing in this population. Publications: Bhandari NR, Hess LM, Parikh RC, Sireci AN, … JA. Biomarker testing in patients diagnosed with advanced/metastatic medullary thyroid cancer in the United States . …
… (T/T) or regorafenib (rego) in patients (pts) with metastatic colorectal cancer (mCRC) in the CodeBreaK 300 study. Taieb J, Fakih MG, …
… 2023 Outstanding Dissertation Award for Research on Breast Cancer Treatment for Older Patients Share on: July 10, 2023 … Treatment Offers Greater Survival for Older Patients with Metastatic Breast Cancer Dr. Ravi Goyal, PhD, a senior … patients with HR+/HER2– metastatic breast cancer. Links to publications: Goyal RK, Chen H, Abughosh SM, Holmes HM, …
… San Antonio Breast Cancer Symposium Share on: Tuesday, December 6 - Saturday, … experts will be presented at the 2022 San Antonio Breast Cancer Symposium. Real-world treatment patterns and clinical … with Eribulin after prior PI3K inhibitor therapy for metastatic breast cancer. Goyal RK, Zhang J, Davis KL, …
… 2023 ESMO Breast Cancer Annual Congress Share on: Thursday, May 11 - … experts will be presented at the 2023 ESMO Breast Cancer Annual Congress. Real-world clinical outcomes … Real-world clinical outcomes among patients (pts) with metastatic/advanced triple-negative breast cancer (mTNBC) in …
Causal Inference for Regulatory-Grade RWE Among the hurdles for making your healthcare interventions available to patients is being able to meet regulatory requirements for estimating the product's safety and/or effectiveness using real-world data (RWD). …
… AI alone in older patients (pts) with de novo, HR+/HER2− metastatic breast cancer: a SEER-Medicare analysis. Brufsky A, Sandin R, … Session Type and Title: Poster Session – Breast Cancer—Metastatic Session Date and Time: 6/2/2024 9:00 AM-12:00 PM …
… will be presented at the ESMO Congress 2023. Breast cancer specific survival (BCSS) in HR+/HER2- metastatic breast cancer (mBC) from 2010 to 2019. Brufsky A, … efficacy outcomes in the VISION study of patients with metastatic castration-resistant prostate cancer. Morris MJ, …
ISOQOL 2023 Share on: Wednesday, October 18 - Saturday, October 21, 2023 Conference website 30 Years of ISOQOL: Quality of Life – making it relevant. Research and presentations by RTI Health Solutions experts are on the program for ISOQOL 2023. An …